Istituto Giannina Gaslini
Genova, Liguria
- UEI
- HXZCB6KWFS49
- CAGE
- AJ393
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Country - Foreign Government
- SAM.gov registration date
- Physical address
- Via Gerolamo Gaslini, 5, 16147 Genova GE, Italy
- Website
- gaslini.org
- Founded
- 1938
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Trustees Of Columbia University In The City Of New York | U01DK100876 | $86,485 | |
| The Trustees Of Columbia University In The City Of New York | U01DK100876 | $86,485 | |
| The Trustees Of Columbia University In The City Of New York | R01DK080099 | $43,999 | |
| The Trustees Of Columbia University In The City Of New York | U01DK100876 | $86,485 |
Similar vendors
About the company
Istituto Giannina Gaslini is a hospital and foundation registered as a foreign government entity to receive U.S. federal grant awards. As a medical research institution, it provides specialized clinical and research services focused on pediatric healthcare and rare diseases. The institute participates in various international collaborative studies, particularly in the areas of nephrology, immunology, and pediatric intensive care. Istituto Giannina Gaslini has been registered in SAM.gov since May 14, 2010, with its current registration valid until April 23, 2025, indicating an ongoing relationship with U.S. federal funding agencies.
Through federal grant sub-awards, Istituto Giannina Gaslini has been involved in several significant research projects. These include studies on glomerulopathies in collaboration with Columbia University, investigating diseases such as IgA nephropathy, focal segmental glomerulosclerosis, membranous nephropathy, and minimal change disease. The institute has also participated in pediatric intensive care research with the University of Pennsylvania, focusing on protocol implementation, patient enrollment, and data collection. Additionally, Istituto Giannina Gaslini has conducted research on lupus nephritis in partnership with the Benaroya Research Institute, examining autoantibody levels as predictors of renal response outcomes. The institute's Laboratory on Pathophysiology of Uremia has been instrumental in these studies, performing tasks such as patient recruitment, biological sample collection, genetic analysis, and long-term patient follow-up. These projects have been funded through various National Institutes of Health programs, including those administered by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID).
Quick answers
Is Istituto Giannina Gaslini registered in SAM.gov?
Yes. Istituto Giannina Gaslini's SAM.gov registration is active through September 30, 2027.
On GovTribe
See Istituto Giannina Gaslini's full federal record
- Similar vendors